ANALYST VALIDATION PROTOCOL CUM REPORT · 2021. 1. 1. · REPORT No. ANALYST VALIDATION PROTOCOL...

26
REPORT No. ANALYST VALIDATION PROTOCOL CUM REPORT SUPERSEDES NIL EFFECTIVE DATE PAGE No. Page 1 of 26 PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT ANALYST VALIDATION PROTOCOL CUM REPORT PROTOCOL No. SUPERSEDES No. NIL EFFECTIVE DATE

Transcript of ANALYST VALIDATION PROTOCOL CUM REPORT · 2021. 1. 1. · REPORT No. ANALYST VALIDATION PROTOCOL...

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 1 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    PROTOCOL No.

    SUPERSEDES No. NIL

    EFFECTIVE DATE

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 2 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    TABLE OF CONTENTS

    Section No Topics Page No.

    1.0 Pre-Approval Signature 03

    2.0 Objective 04

    3.0 Scope 04

    4.0 Responsibilities 04

    5.0 Validation methodology 04

    6.0 Validation test procedure 05

    7.0 Acceptance criteria 06

    8.0 Evaluation of test Result 06

    9.0 Revalidation Frequency 06

    10.0 Conclusion 06

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 3 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    1.0 Pre - Approval

    The Protocol has been prepared, Reviewed and Approved for implementation by the under signed.

    Microbiologist

    PREPARED BY SIGNATURE DATE

    Head Quality Control or Designee

    REVIEWED BY SIGNATURE DATE

    Head Quality Assurance or Designee

    APPROVED BY SIGNATURE DATE

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 4 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2.0 OBJECTIVE:

    The objective of this protocol is to establish and ensure that the microbiologists working in the

    Microbiology Lab of Quality Control Department are capable of performing the Microbial Limit Test as

    per the Pharmacopoeia method.

    3.0 SCOPE:

    This protocol is to qualify the analyst/Trainee for different microbiological testing method as per respective

    STP/GTP in microbiology laboratory at ……………..

    4.0 RESPONSIBILITIES:

    Validation Group consists of following members:

    4.1 QA/QC Department Representative

    Head QA or designee

    Head QC or designee

    Executive-Microbiology

    4.2 Specific Responsibilities

    4.2.1 Microbiologist will write the protocol in consultation with QC/QA Manager.

    4.2.2 Head QC or designee will check the protocol for its completeness, accuracy, technical excellence

    and applicability.

    4.2.3 Head QA or designee will be responsible for final approval of protocol.

    4.2.4 Microbiologist will also be responsible for preparing media, the culture dilution as per the current

    version of SOP.

    5.0 VALIDATION METHODOLOGY:

    5.1 The following tests shall be carried out for the validation of Trainee (Microbiologist).

    (i) Test for Specified Micro organisms

    (ii) Total Viable Aerobic Count

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 5 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    6.0 VALIDATION TEST PROCEDURE:

    Before proceeding for validation following materials are required.

    • Cultures.

    Escherichia coli

    Salmonella sp

    Pseudomonas aeruginosa

    Staphylococcus aureus

    • Sterile Soyabean Casein Digest Medium/Buffered sodium chloride Peptone solution pH 7.0

    • MacConkey agar , MacConkey Broth

    • Rappaport Vassiliadis Salmonella Enrichment Broth, Xylose – Lysine – Deoxycholate Agar

    • Mannitol Salt Agar, Cetrimide Agar

    • N,N,N1,N1 tetramethyl-4-phenylenediamine dihydrochloride or Oxidase disc.

    • Grams staining kit

    6.1 Test for Specified Micro organisms.

    6.1.1 Four previously approved raw materials are used as samples and marked as A, B, C and D for

    identification.

    6.1.2 Deliberately contaminate all the four tube with about 10 – 100 cells of the Microorganism given

    below. (Only Sr. Microbiologist knows the sample) which is contaminated. (One sample for one

    organism)

    - E. coli

    - Salmonella sp.

    - Staphylococcus aureus

    - Pseudomonas aeruginosa

    6.1.3 All the four samples are given to Trainee (Microbiologist) for performing the MLT test as per

    current version of GTP.

    6.1.4 After recommended incubation period the analyst shall observe the results and record the results in

    the format as per Annexure I

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 6 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    6.2 Acceptance Criteria:

    6.2.1 The analyst should correctly identify the organism from all the four deliberately contaminated

    samples [known to supervisor Microbiology]. For screening of Indicator organism should meet the colony

    morphological character on their selective, differential and its specific media plates.

    6.3 Total Viable Aerobic Count:

    6.3.1 Analysed purified water samples are used as samples and marked as E for identification.

    6.4.7 Samples E is given to microbiologist to be qualified for performing the Bioburden test in duplicate

    as per current version of GTP.

    6.3.3 After recommended incubation period the analyst/Trainee shall observe the results.

    6.4.8 The results should be observed by the Analyst/Trainee (Microbiologist) under supervision of supervisor

    microbiology and record the results in the format as per Annexure I.

    Note: Keep one uninoculated media plate as a negative control and sample E should be perform by the approved

    microbiologist along with the trainee microbiologist.

    7.0 ACCEPTANCE CRITERIA:

    7.1 The total aerobic count should be under specification and the observed results should not more or less

    than 10% from previous or parallel analysed samples.

    8.0 EVALUATION:

    8.1 Compliance to the acceptance criteria will establish the Microbiologist is capable of performing the

    limit test.

    8.2 Failure to meet the requirement will require the training of the microbiologist and if in any case the

    retraining is required the microbiologist will be revalidated to perform the said test.

    9.0 SCHEDULE REVALIDATION:

    Revalidation shall be carried out in case of

    ➢ If a new microbiologist joins.

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 7 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    ➢ Each analyst performing the test should re-qualify for every two year.

    10.0 CONCLUSION:

    Summary report will be prepared, which clearly state the successful achievement of objective of validation.

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 8 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    ANNEXURE I

    1. Total Viable Aerobic Count: Date of Testing: ........................

    LAF ID No:…………………

    1.1 Sample Preparation

    Weight/Volume of Sample taken ........gm/ml and transfer in to........ ml of Buffered sodium chloride

    peptone solution /Phosphate buffer/Soyabean casein digest broth Lot No.:.......................

    1.2 Test for Bacterial count:

    Incubator ID No.: .......................

    ......ml of sample preparation transfer in to Petri dish of Soyabean casein digest agar media

    Lot No.: ........................in Duplicate/Single and Incubate at 30-35°C from ………… to…………(3 days)

    Observations:

    Plate

    No. Cfu Average Dilution factor Average x Dilution (Total Bacterial Count/gm/ml)

    Signature & Date: .........................

    1.3 Test for Fungal count (Yeast and Molds):

    Incubator I.D. No.: ......................

    ........ml of sample preparation transfer in to Petri dish of Sabouraud dextrose agar media

    QUALITY CONTROL DEPARTMENT

    Page 8 of 6 DATA SHEET FOR MICROBIOLOGICAL EXAMINATION OF

    NON- STERILE PRODUCTS

    Name of Material/Product Reference

    A.R. No./Inspection Lot. No. Batch No.

    Mfg Date Exp. Date

    Date of Analysis Date of Release

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 9 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    Lot No.:............................ in Duplicate/Single and incubate at 20-25°C from.………… to…………(5-7

    days)

    Observations:

    Plate

    No. Cfu Average Dilution factor Average x Dilution (Total Fungal Count/gm/ml)

    Signature& Date: .........................

    1.4 Total viable aerobic count (cfu/gm/ml) = Bacterial count + Fungal count

    Total viable aerobic count (cfu/gm/ml) =

    Signature& Date: .........................

    2. Test for Specified Micro organisms:

    2.1 Sample preparation and Preincubation:

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Weight / Volume of Sample taken: ........................gm/ml and add to Soyabean casein digest broth Lot No.

    ................ Volume make up to ........ml and incubate at 30-35°C from ................to................ (18-24 hrs.)

    Observation:

    Growth or Turbidity: Observed/Not observed

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.2 Test for Escherichia coli:

    2.2.1 Selection and Sub culture:

    Date of Testing: ………………. Incubator I.D. No.: ......................

    1 ml of pre-enriched media transfer to 100 ml of MacConkey broth Lot No.: ................and incubate at 42-

    44°C from ................to................ (24-48 hrs.)

    Interpretation:

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 10 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    Acid or Gas Produced/Not Produced

    Negative Control: Positive/Negative

    Signature& Date: .........................

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Streak a loop full from the MacConkey broth on preincubated plate of MacConkey agar Lot No.:

    ............................and incubate at 30-35°C from ................to................ (18-72 hrs.)

    Interpretation:

    Red, non-mucoid colonies of gram negative rods: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.2.2 Confirmation:

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Transfer 0.1 ml of pre-enriched media to 5 ml of MacConkey broth Lot No.:………………… and incubate

    at 42-44°C from ................to ................(24-48hrs) add ….ml of Kovac’s reagent.

    Interpretation:

    A red ring of Indole in the upper layer of medium: Present/Absent.

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.3 Salmonella species:

    2.3.1 Selection and Sub culture:

    Date of Testing: ........................ Incubator I.D. No.: ......................

    0.1 ml volume of Soyabean casein digest medium to 10 ml of Rappaport Vassiliadis Salmonella

    enrichment broth Lot No.: .................. and incubate at 30-35°C from ................to................ (18-48hrs.)

    Observation:

    Colour change or Turbidity: Observed/ Not observed

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 11 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    Negative Control: Positive/Negative

    Signature& Date: .........................

    Date of Testing: ........................

    Streak a loop full from the Rappaport Vassiliadis Salmonella enrichment broth on preincubated plate of

    Xylose, lysine, deoxycholate agar medium Lot No.:........................and incubate at 30-35°C from

    ................to................(18-48 hrs.)

    Interpretation:

    Red colonies with or without black centers: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.4 Pseudomonas aeruginosa

    2.4.1 Selection and subculture:

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Streak a loop full from the Soyabean casein digest medium on the surface of preincubated plate of

    Cetrimide agar Medium Lot No.: ................................and incubate at 30-35°C from ................to................

    (18-72 hrs.)

    Interpretation:

    Generally greenish in reflected light and shows fluoresance under UV light: Present/Absent.

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.4.2 Confirmation:

    Date of Testing: ........................

    Oxidase Disc used, Make.: ........................Lot No.: ........................

    Interpretation:

    Development of pink color change to purple (Oxidase positive): Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: .........................

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 12 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2.5 Staphylococcus aureus:

    2.5.1 Selection and subculture:

    Date of Testing: ........................ Incubator I.D. No.: .......................

    Streak a loop full from the enriched culture on the surface of pre incubated plates of Mannitol salt agar Lot

    No.: .................…..and incubate at 30-35°C from ................to................ (18-72 hrs)

    Interpretation:

    Yellow/white colonies surrounded by a yellow zone: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.5.2 Confirmation:

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Transfer the suspected colony from Mannitol salt agar in mammalian plasma and incubate at 37°C from

    ................to................ (24 hrs) and observed the tube for any coagulation at 3 hours of regular interval

    upto 24 hrs.

    Interpretation:

    Coagulation: Observed/Not observed up to 24 hrs.

    Signature& Date: .........................

    2.6 Candida albicans

    2.6.1 Selection and Sub culture:

    Date of Testing: ………………. Incubator I.D. No.: ......................

    10 ml of pre-enriched media transfer to 100 ml of Sabouraud Dextrose broth Lot No.: ................and

    incubate at 30-35°C from ................to................ (3-5 days.).

    Observation:

    Growth or Turbidity: Observed/Not observed

    Negative Control: Positive/Negative

    Signature& Date: .........................

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 13 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2.6.2 Confirmation:

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Streak a loop full from the enriched culture on the surface of pre incubated plates of Sabouraud dextrose

    agar Lot No.: .................…..and incubate at 30-35°C from ................to................ (24-48 hrs)

    Interpretation:

    Growth of white colonies: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.7 Clostridium sporogene:

    2.7.1 Sample preparation and heat treatment.

    Prepare a sample using 1 in 10 dilution of the product and divide into two equal portions not less than 10

    ml. Heat one portion at ………for ………minutes and do not heat other portion.

    2.7.2 Selection and subculture:

    Date of Testing: ........................ Incubator I.D. No.: .......................

    9 ml volume of each Pre-enriched media to 100 ml of Reinforced Medium for Clostridia broth Lot No.:

    .................. and incubate at 30-35°C from ................to................ (48 hrs) under anaerobic condition.

    Observation:

    Color change or Turbidity: Observed/Not observed

    Negative Control: Positive/Negative

    Signature& Date: .........................

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Streak a loop full from the Reinforced Medium for Clostridia on the surface of preincubated plate of

    Columbia agar Medium Lot No.: ................................and incubate at 30-35°C from ................to................

    (48-72 hrs) under anaerobic condition.

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 14 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    Interpretation:

    Growth of rods: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.7.3Confirmation:

    Date of Testing: ........................

    Take suspected colony on the slide and place 2 to 3 drops of 3% H2O2.

    Interpretation:

    Vigorous bubbling: Observed/ Not observed

    Signature& Date: .........................

    2.8 Bile tolerant gram negative bacteria:

    2.8.1 Test for absence

    Date of Testing: ........................ Incubator I.D. No.: ......................

    Weight/Volume of Sample taken: ........................gm/ml and add to ........ml of soyabean casein digest

    Medium Lot No. ................ and incubate at 20-25°C from ................to................(2-5 hrs)

    Transfer 10 ml of above enriched media to 100 ml of Enterobacteria broth mossel Lot No.: ................and

    incubate at 30-35°C from ................to................ (24-48 hrs.)

    Interpretation:

    Growth or Turbidity: Observed/Not observed

    Negative Control: Positive/Negative

    Signature& Date: .........................

    Date of Testing: ………………. Incubator I.D. No.: ......................

    Streak a loop full from the enriched medium on preincubated plate of Violet red bile glucose Agar Lot No.:

    .................. and incubate at 30-35°C from ................to................ (18-24 hrs.)

    Interpretation:

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 15 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    Red colonies surrounded by reddish precipitation zone: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.8.2 Quantitative evaluation

    2.8.2.1 Selection and subculture:

    Date of Testing: ........................ Incubator I.D. No.: .......................

    Inoculate........ml of EE Broth Medium Lot No. ................ with enriched Lactose broth containing 0.1, 0.01

    and 0.001 g/ml of product and incubate at 30-35°C from ................to................ (18-24 hrs)

    Date of Testing: ........................ Incubator I.D. No.: .......................

    Streak a loop full from the enriched medium on preincubated plate of Violet red bile glucose Agar Lot

    No.:..................and incubate at 30-35°C from ................to................(18-24 hrs.)

    Interpretation:

    Note the smallest quantity of the product that gives the positive result and largest quantity that gives

    negative results and determine from the table.

    Negative Control: Positive/Negative

    Observation Table:

    Result for Each Quantity of Product Probable No. of Bacteria per g or ml of

    Product 0.1 g or 0.1 ml 0.01 g or 0.01 ml 0.001 g or 0.001 ml

    + + + More than 104

    + + - Les than 103 and more than 102

    + - - Les than 102 and more than 10

    - - - Less than 10

    Probable no. of Bacteria =………………

    Signature& Date: .........................

    Checked by:…………………….

    (Sign/Date)

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 16 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    1. Total Viable Count: LAF ID No.:……………………...……

    Date of Testing: ........................

    By Filtration Method

    A) Total Aerobic Microbial Count (TAMC) Incubator I.D. No.: ................................

    Dilute……..ml of water sample to ……ml sterile purified water. (Diluted Sample)

    ......ml of diluted sample filtered through membrane filter and place the filter on plate of R2A agar Lot No.:

    ........................ and Incubate at 30-35°C from ………… to…………

    Observations:

    Plate No. cfu Volume of Sample Total Aerobic Microbial Count/ml

    Signature& Date: ...............................

    B) Total Yeast and Mould count (TYMC) Incubator I.D. No.: ............................

    ........ ml of diluted sample filtered through membrane filter and place the filter on plate of Sabouraud dextrose

    agar media Lot No.:......................... and incubate at 20-25°C from ………… to…………

    Observations:

    Plate No. cfu Volume of Sample Total Yeast and Mould count/ml

    Signature& Date: .............................

    ANNEXURE 2

    DATA SHEET FOR MICROBIOLOGICAL ANALYSIS

    Type of Water Reference

    Sampling Point Name A.R. Number

    Sampling Point ID Date of Analysis

    Sampled By Date of Release

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 17 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2. Test for Specified Microorganisms:

    2.1 Sample preparation and Preincubation:

    Date of Testing: ........................ Incubator I.D. No.: .............................

    Volume of Sample filtered: ........................ ml and add the filter to ........ml of Soyabean casein digest broth Lot

    No. ................ and incubate at 30-35°C from ................to................ (18-24 hrs.)

    Observation:

    Growth or Turbidity: Observed/Not observed

    Negative Control: Positive/Negative

    Signature& Date: .........................

    2.2 Test for Escherichia coli:

    2.2.1 Selection and Sub culture:

    Date of Testing: ………………. Incubator I.D. No.: ................................

    1 ml of pre-enriched media transfer to 100 ml of MacConkey broth Lot No.: ................and incubate at 42-44°C

    from ................to................ (24- 48 hrs.)

    Interpretation:

    Acid or Gas Produced/Not Produced

    Negative Control: Positive/Negative

    Signature& Date: ...................................

    Date of Testing: ........................ Incubator I.D. No.: .................................

    Streak a loop full from the MacConkey broth on preincubated plate of MacConkey agar Lot No.:

    ............................and incubate at 30-35°C from ................to................ (18-72 hrs.)

    Interpretation:

    Red, non-mucoid colonies of gram negative rods: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: ..................................

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 18 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2.2.2 Confirmation:

    Date of Testing: ........................ Incubator I.D. No.: ...............................

    Transfer 0.1 ml of pre-enriched media to 5 ml of MacConkey broth Lot No.:………………… and incubate at 42-

    44°C from ................to ................, add ….ml of Kovac’s reagent.

    Interpretation:

    A red ring of Indole in the upper layer of medium: Present/Absent.

    Negative Control: Positive/Negative

    Signature& Date: .................................

    2.3 Salmonella species:

    2.3.1 Selection and Sub culture:

    Date of Testing: ........................ Incubator I.D. No.: ...............................

    0.1 ml volume of Soyabean casein digest medium to 10 ml of Rappaport Vassiliadis Salmonella enrichment broth

    Lot No.: .................. and incubate at 30-35°C from ................to................ (18-48hrs.)

    Observation:

    Colour change or Turbidity: Observed/ Not observed

    Negative Control: Positive/Negative

    Signature& Date: ......................................

    Date of Testing: ........................

    Streak a loop full from the Rappaport Vassiliadis Salmonella enrichment broth on preincubated plate of Xylose,

    lysine, deoxycholate agar medium Lot No.:........................and incubate at 30-35°C from

    ................to................(18-48 hrs.)

    Interpretation:

    Red colonies with or without black centers: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: ......................................

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 19 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2.4 Pseudomonas aeruginosa

    2.4.1 Selection and subculture:

    Date of Testing: ........................ Incubator I.D. No.: ……….......................

    Streak a loop full from the Soyabean casein digest medium on the surface of preincubated plate of Cetrimide agar

    Medium Lot No.: ................................and incubate at 30-35°C from ................to................ (18-72 hrs.)

    Interpretation:

    Generally greenish in reflected light and shows fluoresance under UV light: Present/Absent.

    Negative Control: Positive/Negative

    Signature& Date: ......................................

    2.4.3 Confirmation:

    Date of Testing: ........................

    Oxidase Disc used, Make.: ........................Lot No.: ........................

    Interpretation:

    Development of pink color change to purple (Oxidase positive): Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: ......................................

    2.5 Staphylococcus aureus:

    2.5.1 Selection and subculture:

    Date of Testing: ........................ Incubator I.D. No.: ....................................

    Streak a loop full from the enriched culture on the surface of pre incubated plates of Mannitol salt agar Lot No.:

    .................…..and incubate at 30-35°C from ................to................ (18-72 hrs)

    Interpretation:

    Yellow/white colonies surrounded by a yellow zone: Present/Absent

    Negative Control: Positive/Negative

    Signature& Date: ......................................

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT

    SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 20 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2.5.2 Confirmation:

    Date of Testing: ........................ Incubator I.D. No.: ...................................

    Transfer the suspected colony from Mannitol salt agar in mammalian plasma and incubate at 37°C from

    ................to................ (24 hrs)

    Interpretation:

    Coagulation: Observed/Not observed up to 24 hrs.

    Signature& Date: ......................................

    2.6 Coliforms:

    Date of Testing: ........................ Incubator I.D. No.: ...................................

    ......ml of sample filtered through membrane filter and place the filter on plate of M-Endo agar Lot No.:

    ........................ and Incubate at 30-35°C from ………… to…………(24 hrs).

    Interpretation:

    Red colonies with a metallic sheen.: Observed /Not observed

    Negative Control: Positive/Negative

    Coliforms (cfu/100ml) =………………

    Signature& Date: ......................................

    Checked by:……………..……………….

    (Sign/Date)

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 21 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    ANNEXURE 3

    SUMMARY DATA SHEET FOR MICROBIAL LIMIT TEST

    Prepared By: Checked By:

    (Microbiologist) (Head QC)

    Name of Sample Batch

    No.

    A.R. No. Identification No. Limits Observations

    Existing Microbiologist New Microbiologist

    TBC TFC E. coli Salmo

    nella

    P.

    aerugi

    nosa

    S.

    aureus

    -Ve

    Contr

    ol

    TBC TFC E.

    coli

    Salmonell

    a

    P.

    aeruginosa

    S.

    aureus

    -Ve

    Control

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 22 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    SUMMARY REPORT FOR

    ANALYST VALIDATION

    Analyst Name:…………………..

    PROTOCOL REFERENCE No.

    DATE OF REPORTING

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 23 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    TABLE OF CONTENTS

    Section No. Topics Page No.

    1. Post Approval Signature

    2. Objective

    3. Scope

    4. Responsibility

    5. Acceptance Criteria

    6. Findings and Observations

    7. Remarks and Conclusion of the Study

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 24 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    1.0 Post Approval

    The Summary report has been prepared, Reviewed and Approved for implementation by the under

    signed.

    Microbiologist

    PREPARED BY SIGNATURE DATE

    Head Quality Control or Designee

    REVIEWED BY SIGNATURE DATE

    Head Quality Assurance or Designee

    APPROVED BY SIGNATURE DATE

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 25 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    2.0 OBJECTIVE

    To ensure that the microbiologists working in the Microbiology Lab of Quality Control Department

    is capable of performing the Microbial Limit Test of all products as per GTP.

    3.0 SCOPE

    Applicable to Microbial Limit Test of Product and Purified water.

    4.0 RESPONSIBILITY

    Trainee :

    Trainer :

    Head QC :

    Head QA :

    5.0 ACCEPTANCE CRITERIA

    5.1 The analyst should correctly identify the organism from all the four deliberately contaminated

    samples [known to supervisor Microbiology]. And the result (Bio burden in purified water)

    obtained by both the analyst (Existing Microbiologist & New Microbiologist) should be comparable

    with each other and within the specification limit.

    6.0 FINDINGS AND OBSERVATIONS

    Test Name Product

    /Item Name

    Batch

    No.

    Sample

    Code

    Identification ID Culture added Observation Result

    Pathogen

    testing And

    Total Viable

    Count

    Purified

    Water

    LPW-05 AV-

    001/13

    Sample A E. coli Identify

    Pass

    Sample B Salmonella Identify

    Sample C P. aeruginosa Identify

    Sample D S. aureus Identify

    Sample F …. cfu/ml

    (COA attached)

    …..cfu/ml

  • REPORT No.

    ANALYST VALIDATION

    PROTOCOL CUM REPORT SUPERSEDES NIL

    EFFECTIVE DATE

    PAGE No. Page 26 of 26

    PHARMA SCHOLARS MICROBIOLOGY DEPARTMENT

    7.0 REMARKS AND CONCLUSION OF THE STUDY:

    The results (Total Viable Count) obtained by the trainee and that by the existing microbiologist are

    found to be comparable with each other and also well within the specification limit and identified

    the organism from all the four deliberately contaminated samples [known to supervisor

    Microbiology]. For screening of Indicator organism are meet the colony morphological character on

    their selective, differential and its specific media plates. Thus the analysis of the trainee stands

    validated and is certified to perform by Water/Raw materials/finished Product analysis

    independently as per respective STP/GTP.